Amgad Mentias1, Ghanshyam Shantha2, Oluwaseun Adeola1, Geoffrey D Barnes3, Bharat Narasimhan4, Konstantinos C Siontis2, Deborah A Levine5, Rajan Sah1, Michael C Giudici1, Mary Vaughan Sarrazin6. 1. Division of Cardiovascular Medicine, Roy and Lucille J. Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa. 2. Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109. 3. Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI 48109. 4. Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, NY. 5. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI 48109; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109. 6. Department of Internal Medicine, Roy and Lucille J. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242; Comprehensive Access and Delivery Research and Evaluation Center (CADRE), Iowa City VA Medical Center, Iowa City, IA 52246. Electronic address: mary-vaughan-sarrazin@uiowa.edu.
Abstract
BACKGROUND: Atrial fibrillation (AF) is associated with elevated risk for ischemic stroke and myocardial infarction (MI). The aim of the study is to assess the role of insulin use on the risk of stroke and MI in AF patients with diabetes. METHODS: We identified Medicare beneficiaries with new AF in 2011 to 2013. Primary outcomes were ischemic stroke and MI. Multivariate Cox regression models were used to assess the association between AF and time to stroke and MI. We adjusted for anticoagulant as a time-dependent covariate. RESULTS: Out of 798,592 AF patients, 53,212 (6.7%) were insulin-requiring diabetics (IRD), 250,214 (31.3%) were non-insulin requiring diabetics (NIRD) and 495,166 (62%) were non-diabetics (ND). IRD had a higher risk of stroke when compared to NIRD (adjusted HR: 1.15, 95% CI 1.10-1.21) and ND (aHR 1.24, 95% CI 1.18-1.31) (P < .01 for both). The risk of stroke was higher in NIRD compared to ND (aHR 1.08, 95% CI 1.05-1.12). For the outcome of MI, IRD had a higher risk compared to NIRD (aHR 1.24, 95% CI 1.18-1.31) and ND (aHR 1.46, 95% CI 1.38-1.54)]. NIRD had a higher risk compared to ND (aHR 1.17, 95% CI 1.13-1.22). Anticoagulation were most effective at preventing stroke in ND [0.72 (0.69-0.75)], and NIRD [0.88 (0.85-0.92)], but were not associated with significant reduction in stroke in IRD [0.96 (0.89-1.04)]. CONCLUSION: There is an incremental risk of ischemic stroke and MI from non-diabetics to non-insulin diabetics with the highest risk in insulin users. Protective effect of anticoagulation is attenuated with insulin use. Published by Elsevier Inc.
BACKGROUND:Atrial fibrillation (AF) is associated with elevated risk for ischemic stroke and myocardial infarction (MI). The aim of the study is to assess the role of insulin use on the risk of stroke and MI in AFpatients with diabetes. METHODS: We identified Medicare beneficiaries with new AF in 2011 to 2013. Primary outcomes were ischemic stroke and MI. Multivariate Cox regression models were used to assess the association between AF and time to stroke and MI. We adjusted for anticoagulant as a time-dependent covariate. RESULTS: Out of 798,592 AFpatients, 53,212 (6.7%) were insulin-requiring diabetics (IRD), 250,214 (31.3%) were non-insulin requiring diabetics (NIRD) and 495,166 (62%) were non-diabetics (ND). IRD had a higher risk of stroke when compared to NIRD (adjusted HR: 1.15, 95% CI 1.10-1.21) and ND (aHR 1.24, 95% CI 1.18-1.31) (P < .01 for both). The risk of stroke was higher in NIRD compared to ND (aHR 1.08, 95% CI 1.05-1.12). For the outcome of MI, IRD had a higher risk compared to NIRD (aHR 1.24, 95% CI 1.18-1.31) and ND (aHR 1.46, 95% CI 1.38-1.54)]. NIRD had a higher risk compared to ND (aHR 1.17, 95% CI 1.13-1.22). Anticoagulation were most effective at preventing stroke in ND [0.72 (0.69-0.75)], and NIRD [0.88 (0.85-0.92)], but were not associated with significant reduction in stroke in IRD [0.96 (0.89-1.04)]. CONCLUSION: There is an incremental risk of ischemic stroke and MI from non-diabetics to non-insulin diabetics with the highest risk in insulin users. Protective effect of anticoagulation is attenuated with insulin use. Published by Elsevier Inc.
Authors: T A Elhadd; G Kennedy; A Hill; M McLaren; R W Newton; S A Greene; J J Belch Journal: Diabetes Metab Res Rev Date: 1999 Nov-Dec Impact factor: 4.876
Authors: Steven P Marso; Stephen C Bain; Agostino Consoli; Freddy G Eliaschewitz; Esteban Jódar; Lawrence A Leiter; Ildiko Lingvay; Julio Rosenstock; Jochen Seufert; Mark L Warren; Vincent Woo; Oluf Hansen; Anders G Holst; Jonas Pettersson; Tina Vilsbøll Journal: N Engl J Med Date: 2016-09-15 Impact factor: 91.245
Authors: Wesley T O'Neal; Elsayed Z Soliman; George Howard; Virginia J Howard; Monika M Safford; Mary Cushman; Neil A Zakai Journal: Atherosclerosis Date: 2015-09-08 Impact factor: 5.162
Authors: Dwayne S G Conway; Lesly A Pearce; Bernard S P Chin; Robert G Hart; Gregory Y H Lip Journal: Circulation Date: 2002-10-08 Impact factor: 29.690
Authors: P Fasching; M Veitl; M Rohac; C Streli; B Schneider; W Waldhäusl; O F Wagner Journal: J Clin Endocrinol Metab Date: 1996-12 Impact factor: 5.958
Authors: C el Khawand; J Jamart; J Donckier; B Chatelain; E Lavenne; M Moriau; M Buysschaert Journal: Diabetes Care Date: 1993-08 Impact factor: 19.112
Authors: Alan S Go; Elaine M Hylek; Yuchiao Chang; Kathleen A Phillips; Lori E Henault; Angela M Capra; Nancy G Jensvold; Joe V Selby; Daniel E Singer Journal: JAMA Date: 2003-11-26 Impact factor: 56.272
Authors: Giuseppe Patti; Markus Lucerna; Ilaria Cavallari; Elisabetta Ricottini; Giulia Renda; Ladislav Pecen; Fabio Romeo; Jean-Yves Le Heuzey; Josè Luis Zamorano; Paulus Kirchhof; Raffaele De Caterina Journal: J Am Coll Cardiol Date: 2017-01-31 Impact factor: 24.094
Authors: Husam Abdel-Qadir; Madison Gunn; Iliana C Lega; Andrea Pang; Peter C Austin; Sheldon M Singh; Cynthia A Jackevicius; Karen Tu; Paul Dorian; Douglas S Lee; Dennis T Ko Journal: J Am Heart Assoc Date: 2022-02-08 Impact factor: 6.106
Authors: Dana Prídavková; Matej Samoš; Tomáš Bolek; Ingrid Škorňová; Jana Žolková; Peter Kubisz; Ján Staško; Marián Mokáň Journal: J Diabetes Res Date: 2019-12-06 Impact factor: 4.011
Authors: Francis E Ugowe; Anne S Hellkamp; Allen Wang; Richard C Becker; Scott D Berkowitz; Günter Breithardt; Keith A A Fox; Jonathan L Halperin; Graeme J Hankey; Kenneth W Mahaffey; Christopher C Nessel; Daniel E Singer; Manesh R Patel; Jonathan P Piccini Journal: Heart Rhythm O2 Date: 2021-04-20